Lord, Abbett & Co Portfolio holdings
AUM
$31.1B
This Quarter Return
+4.35%
1 Year Return
+47.41%
3 Year Return
+216.81%
5 Year Return
+576.69%
10 Year Return
+1,917.93%
AUM
$41.8B
AUM Growth
+$41.8B
(+0.79%)
Cap. Flow
+$437M
Cap. Flow
% of AUM
1.05%
Top 10 Holdings %
Top 10 Hldgs %
12.66%
Holding
739
New
78
Increased
203
Reduced
266
Closed
85
Top Buys
| 1 |
NVIDIA
NVDA
|
$372M |
| 2 |
lululemon athletica
LULU
|
$246M |
| 3 |
Tesla
TSLA
|
$232M |
| 4 |
DexCom
DXCM
|
$216M |
| 5 |
Netflix
NFLX
|
$191M |
Top Sells
| 1 |
Amazon
AMZN
|
$226M |
| 2 |
Meta Platforms (Facebook)
META
|
$225M |
| 3 |
Intuitive Surgical
ISRG
|
$224M |
| 4 |
FIVE9
FIVN
|
$210M |
| 5 |
Mastercard
MA
|
$151M |
Sector Composition
| 1 | Technology | 22.91% |
| 2 | Healthcare | 13.55% |
| 3 | Financials | 13.38% |
| 4 | Consumer Discretionary | 12.85% |
| 5 | Industrials | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
151
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $86.9M | 0.21% | 793,315 +238,789 | +43% | +$26.2M |
|
|
PDCE
152
DELISTED
PDC Energy, Inc.
PDCE
| $86.2M | 0.21% | 1,819,379 +437,502 | +32% | +$20.7M |
|
153
CMS Energy
CMS
$21.4B
| $85.9M | 0.21% | 1,438,724 -43,604 | -3% | -$2.6M |
|
154
Carvana
CVNA
$51.4B
| $85.8M | 0.21% | +284,478 | New | +$85.8M |
|
|
MRTX
155
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $83.9M | 0.2% | 474,091 +116,561 | +33% | +$20.6M |
|
156
Crown Castle
CCI
$43.2B
| $83.8M | 0.2% | 483,221 -465,407 | -49% | -$80.7M |
|
|
SI
157
DELISTED
Silvergate Capital Corporation
SI
| $83.6M | 0.2% | 723,944 -20,818 | -3% | -$2.4M |
|
158
Citigroup
C
$178B
| $83.1M | 0.2% | 1,184,091 -156,652 | -12% | -$11M |
|
159
Dollar General
DG
$23.9B
| $82.5M | 0.2% | 388,800 -300 | -0.1% | -$63.6K |
|
160
Alcoa
AA
$8.33B
| $78.7M | 0.19% | +1,609,021 | New | +$78.7M |
|
161
Equitable Holdings
EQH
$16B
| $78.2M | 0.19% | 2,639,863 -118,218 | -4% | -$3.5M |
|
162
General Motors
GM
$55.8B
| $78.2M | 0.19% | 1,483,997 -126,705 | -8% | -$6.68M |
|
|
ITCI
163
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $77.8M | 0.19% | 2,088,034 -57,554 | -3% | -$2.15M |
|
164
Bank of America
BAC
$376B
| $77.8M | 0.19% | 1,833,153 -835,045 | -31% | -$35.4M |
|
|
EVBG
165
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $77.5M | 0.19% | 513,191 +222,972 | +77% | +$33.7M |
|
166
National Vision
EYE
$1.82B
| $77.1M | 0.18% | 1,357,293 -43,242 | -3% | -$2.45M |
|
167
Unity
U
$16.7B
| $77M | 0.18% | +610,186 | New | +$77M |
|
168
Microchip Technology
MCHP
$35.1B
| $76.5M | 0.18% | 498,356 +5,395 | +1% | +$828K |
|
169
Pfizer
PFE
$141B
| $75.3M | 0.18% | +1,750,058 | New | +$75.3M |
|
170
Bristol-Myers Squibb
BMY
$96B
| $74.6M | 0.18% | 1,260,707 -73,954 | -6% | -$4.38M |
|
171
Rush Enterprises Class A
RUSHA
$4.47B
| $73.4M | 0.18% | 1,625,857 -47,324 | -3% | -$2.14M |
|
172
American International
AIG
$45.1B
| $72.7M | 0.17% | 1,324,205 +308,074 | +30% | +$16.9M |
|
173
Yeti Holdings
YETI
$2.86B
| $72.6M | 0.17% | 847,258 -129,983 | -13% | -$11.1M |
|
174
Globant
GLOB
$2.96B
| $71.7M | 0.17% | 255,202 -116,691 | -31% | -$32.8M |
|
175
Burlington
BURL
$18.3B
| $71M | 0.17% | 250,523 -106,528 | -30% | -$30.2M |
|